49
Growth Score
pts
Heat Score
-26 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
863053
CMTx Biotech focuses on repurposing a clinical-stage small molecule for the treatment of COVID-19 patients.
- James Keane: Co-Founder and COO
Carlos N. Velez: Vice President Of Business DevelopmentPast Role: Ventac Partners, Partner
About the Company
CMTx Biotech is a clinical-stage biopharmaceutical company that focuses on repurposing a clinical-stage small molecule for the treatment of COVID-19 patients. It is currently preparing to advance into a Phase II clinical trial to demonstrate the safety and efficacy of its drug candidate in hospitalized COVID-19 patients.
The company was founded in
2019 and is headquartered in Stony Brook, New York.
